ID   E2AK3_HUMAN             Reviewed;        1116 AA.
AC   Q9NZJ5; A0AVH1; A0AVH2; B2RCU9; O95846; Q53QY0; Q53SB1;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   02-NOV-2010, entry version 104.
DE   RecName: Full=Eukaryotic translation initiation factor 2-alpha kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=PRKR-like endoplasmic reticulum kinase;
DE   AltName: Full=Pancreatic eIF2-alpha kinase;
DE            Short=HsPEK;
DE   Flags: Precursor;
GN   Name=EIF2AK3; Synonyms=PEK, PERK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANTS ARG-166 AND
RP   SER-704.
RC   TISSUE=Liver, Pancreas, and Testis;
RX   MEDLINE=99150360; PubMed=10026192; DOI=10.1074/jbc.274.9.5723;
RA   Shi Y., An J., Liang J., Hayes S.E., Sandusky G.E., Stramm L.E.,
RA   Yang N.N.;
RT   "Characterization of a mutant pancreatic eIF-2alpha kinase, PEK, and
RT   co-localization with somatostatin in islet delta cells.";
RL   J. Biol. Chem. 274:5723-5730(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANTS ARG-166 AND
RP   SER-704.
RC   TISSUE=Brain, and Pancreas;
RX   MEDLINE=20143423; PubMed=10677345; DOI=10.1042/0264-6021:3460281;
RA   Sood R., Porter A.C., Ma K., Quilliam L.A., Wek R.C.;
RT   "Pancreatic eukaryotic initiation factor-2alpha kinase (PEK)
RT   homologues in humans, Drosophila melanogaster and Caenorhabditis
RT   elegans that mediate translational control in response to endoplasmic
RT   reticulum stress.";
RL   Biochem. J. 346:281-293(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT WRS GLN-588, AND VARIANT
RP   CYS-136.
RX   MEDLINE=20392391; PubMed=10932183; DOI=10.1038/78085;
RA   Delepine M., Nicolino M., Barrett T., Golamaully M., Lathrop G.M.,
RA   Julier C.;
RT   "EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is
RT   mutated in patients with Wolcott-Rallison syndrome.";
RL   Nat. Genet. 25:406-409(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-166 AND
RP   SER-704.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-715, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-136; VAL-566 AND LEU-716.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Phosphorylates the alpha subunit of eukaryotic
CC       translation-initiation factor 2 (EIF2), leading to its
CC       inactivation and thus to a rapid reduction of translational
CC       initiation and repression of global protein synthesis. Serves as a
CC       critical effector of unfolded protein response (UPR)-induced G1
CC       growth arrest due to the loss of cyclin D1 (By similarity).
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Perturbation in protein folding in the
CC       endoplasmic reticulum (ER) promotes reversible dissociation from
CC       HSPA5/BIP and oligomerization, resulting in
CC       transautophosphorylation and kinase activity induction (By
CC       similarity).
CC   -!- SUBUNIT: Forms dimers with HSPA5/BIP in resting cells.
CC       Oligomerizes in ER-stressed cells. Interacts with DNAJC3 (By
CC       similarity).
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-766076, EBI-766076;
CC       P14625:HSP90B1; NbExp=1; IntAct=EBI-766076, EBI-359129;
CC       P11021:HSPA5; NbExp=1; IntAct=EBI-766076, EBI-354921;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass
CC       type I membrane protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitous. A high level expression is seen in
CC       secretory tissues.
CC   -!- INDUCTION: By endoplasmic reticulum stress.
CC   -!- DOMAIN: The lumenal domain senses perturbations in protein folding
CC       in the ER, probably through reversible interaction with HSPA5/BIP
CC       (By similarity).
CC   -!- PTM: Autophosphorylated.
CC   -!- PTM: N-glycosylated (By similarity).
CC   -!- DISEASE: Defects in EIF2AK3 are the cause of Wolcott-Rallison
CC       syndrome (WRS) [MIM:226980]; also known as multiple epiphyseal
CC       dysplasia with early-onset diabetes mellitus. WRS is a rare
CC       autosomal recessive disorder, characterized by permanent neonatal
CC       or early infancy insulin-dependent diabetes and, at a later age,
CC       epiphyseal dysplasia, osteoporosis, growth retardation and other
CC       multisystem manifestations, such as hepatic and renal
CC       dysfunctions, mental retardation and cardiovascular abnormalities.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. GCN2 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/EIF2AK3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF110146; AAD19961.1; -; mRNA.
DR   EMBL; AF193339; AAF61199.1; -; mRNA.
DR   EMBL; AF284615; AAF91480.1; -; Genomic_DNA.
DR   EMBL; AF284604; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284605; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284606; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284607; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284608; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284609; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284610; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284611; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284612; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284613; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AF284614; AAF91480.1; JOINED; Genomic_DNA.
DR   EMBL; AK315287; BAG37696.1; -; mRNA.
DR   EMBL; AC062029; AAY14777.1; -; Genomic_DNA.
DR   EMBL; AC104134; AAY24331.1; -; Genomic_DNA.
DR   EMBL; BC126354; AAI26355.1; -; mRNA.
DR   EMBL; BC126356; AAI26357.1; -; mRNA.
DR   IPI; IPI00303053; -.
DR   RefSeq; NP_004827.4; -.
DR   UniGene; Hs.591589; -.
DR   ProteinModelPortal; Q9NZJ5; -.
DR   SMR; Q9NZJ5; 103-465, 588-1077.
DR   IntAct; Q9NZJ5; 6.
DR   STRING; Q9NZJ5; -.
DR   PhosphoSite; Q9NZJ5; -.
DR   PRIDE; Q9NZJ5; -.
DR   Ensembl; ENST00000303236; ENSP00000307235; ENSG00000172071.
DR   GeneID; 9451; -.
DR   KEGG; hsa:9451; -.
DR   CTD; 9451; -.
DR   GeneCards; GC02M088758; -.
DR   H-InvDB; HIX0023925; -.
DR   H-InvDB; HIX0030379; -.
DR   HGNC; HGNC:3255; EIF2AK3.
DR   HPA; CAB009204; -.
DR   HPA; HPA015737; -.
DR   MIM; 226980; phenotype.
DR   MIM; 604032; gene.
DR   Orphanet; 1667; Wolcott-Rallison syndrome.
DR   PharmGKB; PA27687; -.
DR   HOVERGEN; HBG051431; -.
DR   InParanoid; Q9NZJ5; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_15380; Diabetes pathways.
DR   ArrayExpress; Q9NZJ5; -.
DR   Bgee; Q9NZJ5; -.
DR   CleanEx; HS_EIF2AK3; -.
DR   Genevestigator; Q9NZJ5; -.
DR   GermOnline; ENSG00000172071; Homo sapiens.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; NAS:UniProtKB.
DR   GO; GO:0016021; C:integral to membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004694; F:eukaryotic translation initiation factor 2a...; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0006919; P:activation of caspase activity; ISS:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0002063; P:chondrocyte development; ISS:UniProtKB.
DR   GO; GO:0031018; P:endocrine pancreas development; IMP:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; ISS:UniProtKB.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein resp...; IDA:UniProtKB.
DR   GO; GO:0006983; P:ER overload response; IDA:UniProtKB.
DR   GO; GO:0030073; P:insulin secretion; ISS:UniProtKB.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signali...; ISS:UniProtKB.
DR   GO; GO:0031642; P:negative regulation of myelination; ISS:UniProtKB.
DR   GO; GO:0032057; P:negative regulation of translational initia...; TAS:UniProtKB.
DR   GO; GO:0046777; P:protein amino acid autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IMP:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR011047; Quino_AlcDH-like.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Gene3D; G3DSA:2.140.10.10; Quinoprotein_alc_DH-like; 1.
DR   Pfam; PF00069; Pkinase; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF50998; Quin_alc_DH_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Diabetes mellitus; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Signal; Stress response; Transferase;
KW   Translation regulation; Transmembrane; Transmembrane helix;
KW   Unfolded protein response.
FT   SIGNAL        1     29       Potential.
FT   CHAIN        30   1116       Eukaryotic translation initiation factor
FT                                2-alpha kinase 3.
FT                                /FTId=PRO_0000024322.
FT   TOPO_DOM     30    514       Lumenal (Potential).
FT   TRANSMEM    515    535       Helical; (Potential).
FT   TOPO_DOM    536   1116       Cytoplasmic (Potential).
FT   DOMAIN      593   1077       Protein kinase.
FT   NP_BIND     599    607       ATP (By similarity).
FT   COMPBIAS     49     52       Poly-Ala.
FT   ACT_SITE    937    937       Proton acceptor (By similarity).
FT   BINDING     622    622       ATP (By similarity).
FT   MOD_RES     715    715       Phosphoserine.
FT   CARBOHYD    258    258       N-linked (GlcNAc...) (Potential).
FT   VARIANT     136    136       S -> C (in dbSNP:rs867529).
FT                                /FTId=VAR_011409.
FT   VARIANT     166    166       Q -> R (in dbSNP:rs13045).
FT                                /FTId=VAR_011410.
FT   VARIANT     566    566       D -> V.
FT                                /FTId=VAR_040477.
FT   VARIANT     588    588       R -> Q (in WRS; in a Pakistani family;
FT                                probable complete loss of activity).
FT                                /FTId=VAR_011408.
FT   VARIANT     704    704       A -> S (in dbSNP:rs1805165).
FT                                /FTId=VAR_011411.
FT   VARIANT     716    716       P -> L.
FT                                /FTId=VAR_040478.
FT   CONFLICT     14     14       Missing (in Ref. 1; AAD19961, 2;
FT                                AAF61199, 3; AAF91480, 4; BAG37696 and 6;
FT                                AAI26357).
FT   CONFLICT    490    490       N -> H (in Ref. 2; AAF61199).
SQ   SEQUENCE   1116 AA;  125216 MW;  95FEB5DAE8D3D452 CRC64;
     MERAISPGLL VRALLLLLLL LGLAARTVAA GRARGLPAPT AEAAFGLGAA AAPTSATRVP
     AAGAVAAAEV TVEDAEALPA AAGEQEPRGP EPDDETELRP RGRSLVIIST LDGRIAALDP
     ENHGKKQWDL DVGSGSLVSS SLSKPEVFGN KMIIPSLDGA LFQWDQDRES METVPFTVES
     LLESSYKFGD DVVLVGGKSL TTYGLSAYSG KVRYICSALG CRQWDSDEME QEEDILLLQR
     TQKTVRAVGP RSGNEKWNFS VGHFELRYIP DMETRAGFIE STFKPNENTE ESKIISDVEE
     QEAAIMDIVI KVSVADWKVM AFSKKGGHLE WEYQFCTPIA SAWLLKDGKV IPISLFDDTS
     YTSNDDVLED EEDIVEAARG ATENSVYLGM YRGQLYLQSS VRISEKFPSS PKALESVTNE
     NAIIPLPTIK WKPLIHSPSR TPVLVGSDEF DKCLSNDKFS HEEYSNGALS ILQYPYDNGY
     YLPYYKRERN KRSTQITVRF LDNPHYNKNI RKKDPVLLLH WWKEIVATIL FCIIATTFIV
     RRLFHPHPHR QRKESETQCQ TENKYDSVSG EANDSSWNDI KNSGYISRYL TDFEPIQCLG
     RGGFGVVFEA KNKVDDCNYA IKRIRLPNRE LAREKVMREV KALAKLEHPG IVRYFNAWLE
     APPEKWQEKM DEIWLKDEST DWPLSSPSPM DAPSVKIRRM DPFATKEHIE IIAPSPQRSR
     SFSVGISCDQ TSSSESQFSP LEFSGMDHED ISESVDAAYN LQDSCLTDCD VEDGTMDGND
     EGHSFELCPS EASPYVRSRE RTSSSIVFED SGCDNASSKE EPKTNRLHIG NHCANKLTAF
     KPTSSKSSSE ATLSISPPRP TTLSLDLTKN TTEKLQPSSP KVYLYIQMQL CRKENLKDWM
     NGRCTIEERE RSVCLHIFLQ IAEAVEFLHS KGLMHRDLKP SNIFFTMDDV VKVGDFGLVT
     AMDQDEEEQT VLTPMPAYAR HTGQVGTKLY MSPEQIHGNS YSHKVDIFSL GLILFELLYP
     FSTQMERVRT LTDVRNLKFP PLFTQKYPCE YVMVQDMLSP SPMERPEAIN IIENAVFEDL
     DFPGKTVLRQ RSRSLSSSGT KHSRQSNNSH SPLPSN
//
